Leukemic phase of mantle cell lymphoma, blastoid variant

Am J Clin Pathol. 1999 Apr;111(4):495-500. doi: 10.1093/ajcp/111.4.495.

Abstract

Six patients with mantle cell lymphoma, blastoid variant, involving the blood are described. The circulating blast-like cells suggested the possibility of acute leukemias, chronic lymphoproliferative disorders or peripheralized lymphomas. The WBC counts ranged from 3,700 to 249,000/microL (3.7-249.0 x 10(9)/L) and the absolute lymphocyte counts from 1,000 to more than 200,000/microL (1.0 to > 200.0 x 10(9)/L). The peripheral blood smears showed a spectrum of cells, from small mature lymphocytes with irregular nuclei to medium-sized lymphocytes with blast-like chromatin. However, the morphologic features in a lymph node biopsy specimen and the immunophenotype confirmed a diagnosis of mantle cell lymphoma, blastoid variant. By flow cytometry the lymphoma cells expressed B-cell-associated antigens (CD19, CD20 and CD22), coexpressed CD5, lacked CD23, and expressed moderate intensity monoclonal surface immunoglobulin and CD20. Cytogenetic analysis showed the characteristic t(11;14) in 2 of 4 analyzed specimens. Mantle cell lymphoma, blastoid variant, is part of the differential diagnosis for blast-like cells.

MeSH terms

  • Aged
  • Antibodies, Monoclonal / analysis
  • Antigens, Differentiation, B-Lymphocyte / analysis
  • Bone Marrow Cells / pathology
  • Cell Nucleus / pathology
  • Chromatin / pathology
  • Female
  • Flow Cytometry
  • Hepatomegaly
  • Humans
  • Immunophenotyping
  • Leukocyte Count
  • Lymph Nodes / pathology
  • Lymphocyte Count
  • Lymphocytes / pathology
  • Lymphocytes / ultrastructure
  • Lymphoma, Non-Hodgkin / diagnosis
  • Lymphoma, Non-Hodgkin / immunology
  • Lymphoma, Non-Hodgkin / pathology*
  • Male
  • Middle Aged
  • Splenomegaly

Substances

  • Antibodies, Monoclonal
  • Antigens, Differentiation, B-Lymphocyte
  • Chromatin